Annual FCF:
-$44.17M+$8.25M(+15.74%)Summary
- As of today, JANX annual free cash flow is -$44.17 million, with the most recent change of +$8.25 million (+15.74%) on December 31, 2024.
- During the last 3 years, JANX annual free cash flow has fallen by -$25.71 million (-139.32%).
- JANX annual free cash flow is now -1053.94% below its all-time high of -$3.83 million, reached on December 31, 2019.
Performance
JANX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$12.95M+$11.34M(+46.68%)Summary
- As of today, JANX quarterly free cash flow is -$12.95 million, with the most recent change of +$11.34 million (+46.68%) on September 30, 2025.
- Over the past year, JANX quarterly free cash flow has dropped by -$10.69 million (-473.98%).
- JANX quarterly free cash flow is now -339.35% below its all-time high of $5.41 million, reached on March 31, 2021.
Performance
JANX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$71.40M-$10.69M(-17.61%)Summary
- As of today, JANX TTM free cash flow is -$71.40 million, with the most recent change of -$10.69 million (-17.61%) on September 30, 2025.
- Over the past year, JANX TTM free cash flow has dropped by -$33.58 million (-88.77%).
- JANX TTM free cash flow is now -2113.45% below its all-time high of $3.55 million, reached on March 31, 2021.
Performance
JANX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
JANX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +15.7% | -474.0% | -88.8% |
| 3Y3 Years | -139.3% | +18.7% | -51.7% |
| 5Y5 Years | -1053.9% | -1095.7% | -2505.7% |
JANX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -139.3% | +15.7% | -474.0% | +46.7% | -88.8% | at low |
| 5Y | 5-Year | -1053.9% | +15.7% | -339.4% | +46.7% | -2113.4% | at low |
| All-Time | All-Time | -1053.9% | +15.7% | -339.4% | +46.7% | -2113.4% | at low |
JANX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$12.95M(+46.7%) | -$71.40M(-17.6%) |
| Jun 2025 | - | -$24.29M(-39.6%) | -$60.70M(-30.5%) |
| Mar 2025 | - | -$17.39M(-3.7%) | -$46.53M(-5.3%) |
| Dec 2024 | -$44.17M(+15.7%) | -$16.77M(-643.2%) | -$44.17M(-16.8%) |
| Sep 2024 | - | -$2.26M(+77.7%) | -$37.82M(+20.8%) |
| Jun 2024 | - | -$10.12M(+32.7%) | -$47.74M(+10.4%) |
| Mar 2024 | - | -$15.03M(-44.3%) | -$53.26M(-1.6%) |
| Dec 2023 | -$52.42M(-6.2%) | -$10.42M(+14.5%) | -$52.42M(+6.3%) |
| Sep 2023 | - | -$12.18M(+22.1%) | -$55.98M(+6.3%) |
| Jun 2023 | - | -$15.63M(-10.1%) | -$59.73M(-17.0%) |
| Mar 2023 | - | -$14.20M(-1.6%) | -$51.07M(-3.4%) |
| Dec 2022 | -$49.37M | -$13.97M(+12.3%) | -$49.37M(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$15.93M(-128.6%) | -$47.05M(-27.0%) |
| Jun 2022 | - | -$6.97M(+44.2%) | -$37.05M(-1.9%) |
| Mar 2022 | - | -$12.49M(-7.2%) | -$36.36M(-97.0%) |
| Dec 2021 | -$18.46M(-322.5%) | -$11.65M(-96.5%) | -$18.46M(-171.3%) |
| Sep 2021 | - | -$5.93M(+5.6%) | -$6.80M(-247.9%) |
| Jun 2021 | - | -$6.28M(-216.1%) | -$1.96M(-155.2%) |
| Mar 2021 | - | $5.41M(+599.5%) | $3.55M(+229.4%) |
| Dec 2020 | -$4.37M(-14.1%) | - | - |
| Sep 2020 | - | -$1.08M(-38.7%) | -$2.74M(-65.4%) |
| Jun 2020 | - | -$781.00K(+10.8%) | -$1.66M(-89.2%) |
| Mar 2020 | - | -$876.00K | -$876.00K |
| Dec 2019 | -$3.83M | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Janux Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Janux Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Janux Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of JANX is -$44.17M
What is the all-time high annual free cash flow for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual free cash flow is -$3.83M
What is Janux Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, JANX annual free cash flow has changed by +$8.25M (+15.74%)
What is Janux Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of JANX is -$12.95M
What is the all-time high quarterly free cash flow for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly free cash flow is $5.41M
What is Janux Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, JANX quarterly free cash flow has changed by -$10.69M (-473.98%)
What is Janux Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of JANX is -$71.40M
What is the all-time high TTM free cash flow for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM free cash flow is $3.55M
What is Janux Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, JANX TTM free cash flow has changed by -$33.58M (-88.77%)